Vital Farms Faces Investor Misleading Allegations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 11 2026
0mins
Should l Buy VITL?
Source: Newsfilter
- Lawsuit Allegations: Robbins LLP is investigating whether Vital Farms, Inc. (VITL) misled investors between May 8, 2025, and February 26, 2026, by emphasizing the critical nature of its enterprise resource planning (ERP) system implementation while delaying it, which led to shipment and production delays affecting retail shelf space.
- Financial Performance Miss: The 10-K report released by Vital Farms on February 26, 2026, revealed a revenue of $759.44 million for fiscal year 2025, falling short of the $775 million guidance, with earnings per share (EPS) reported at $0.35, below the market consensus of $0.39, indicating significant operational challenges.
- Stock Price Reaction: Following the release of the disappointing financial report, Vital Farms' stock price dropped by $2.68, or 10.8%, closing at $22.11, reflecting market concerns about the company's future prospects and potentially diminishing investor confidence.
- Class Action Opportunity: Affected shareholders have the opportunity to submit their applications by May 26, 2026, to serve as lead plaintiffs in the class action, representing other shareholders and highlighting investor concerns regarding corporate governance and management accountability.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VITL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VITL
Wall Street analysts forecast VITL stock price to rise
12 Analyst Rating
11 Buy
0 Hold
1 Sell
Strong Buy
Current: 9.170
Low
44.00
Averages
48.90
High
60.00
Current: 9.170
Low
44.00
Averages
48.90
High
60.00
About VITL
Vital Farms, Inc. offers a range of ethically produced foods nationwide. The Company is a national consumer brand that works with more than 575 family farms and is the United States brand of pasture-raised eggs. The Company focuses on the humane treatment of farm animals and sustainable farming practices. The Company packages, markets and distributes shell eggs, butter, and other products. Its products, including shell eggs, butter, hard-boiled eggs, and liquid whole eggs, are sold in approximately 23,500 stores nationwide. The retail varieties of its shell eggs are based on supplemental feed type, egg size, and pack size. Its egg packaging consists primarily of corrugated boxes and egg cartons. The Company offers unsalted and sea-salted varieties of its butter, which are sold in two-stick and four-stick packs. The Company’s products are principally sold under the name Vital Farms in addition to other trade names, primarily to retail and foodservice channels in the United States.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Litigation Background: Robbins LLP is investigating allegations that Vital Farms, Inc. (VITL) misled investors regarding its business prospects during the class period from May 8, 2025, to February 26, 2026, raising serious concerns about the company's transparency.
- Financial Misses: In its February 26, 2026, 10-K report, Vital Farms reported fiscal year 2025 revenue of $759.44 million, missing the $775 million guidance, and an earnings per share (EPS) of $0.35, below the market consensus of $0.39, indicating a significant decline in performance.
- ERP Implementation Issues: Despite emphasizing the importance of the enterprise resource planning (ERP) system for operations, delays in its implementation led to shipment and production disruptions, potentially harming retail shelf space and the company's market position in the long term.
- Stock Price Reaction: Following the release of the disappointing financial report, Vital Farms' stock fell by $2.68, or 10.8%, closing at $22.11, reflecting increasing investor concerns about the company's future prospects, which could impact its financing and market credibility.
See More
- Significant Stock Decline: On February 26, 2026, Vital Farms' shares fell by $2.68, a 10.8% drop, closing at $22.11, reflecting investor disappointment over the company's fiscal year 2025 revenue of $759.4 million, which missed its raised guidance of at least $775 million, indicating concerns about its financial health.
- Legal Scrutiny: Levi & Korsinsky, LLP is examining whether Vital Farms' risk disclosures were adequate during the class period from May 8, 2025, to February 26, 2026, alleging that the company failed to timely update risk information related to its ERP system implementation, potentially leading to investor losses.
- Inadequate Risk Disclosures: The lawsuit claims that by the time the 3Q 2025 10-Q was filed, the ERP system was already live and causing production slowdowns, yet the company continued to use vague risk warnings, failing to disclose the actual production delays, which could mislead investors.
- Investor Protection Steps: Investors are advised to gather their purchase records and contact the law firm for a free evaluation, indicating that in securities class actions, investors still have opportunities to recover losses, highlighting the legal protections available for investor rights.
See More
- Class Action Initiated: Bragar Eagel & Squire, P.C. has filed a class action lawsuit against Vital Farms in the U.S. District Court for the Western District of Texas, representing investors who purchased securities between May 8, 2025, and February 26, 2026, indicating significant investor dissatisfaction with the company's financial transparency.
- False Statement Allegations: The complaint alleges that Vital Farms misled investors by downplaying the impact of delays caused by its new enterprise resource planning (ERP) system, resulting in the company missing consensus earnings per share, which directly undermines investor confidence.
- Investor Losses: As the market learned the truth about Vital Farms, investors suffered significant losses, reflecting serious failures in the company's disclosure practices that could lead to stock price declines and affect future financing capabilities.
- Legal Consultation Opportunity: Investors are encouraged to apply to be lead plaintiffs in the lawsuit by May 26, 2026, highlighting that legal avenues provide a chance for affected investors to seek compensation, potentially impacting the company's future legal and financial standing.
See More
- Class Action Notice: Rosen Law Firm reminds investors who purchased Vital Farms (NASDAQ: VITL) securities between May 8, 2025, and February 26, 2026, that they must apply to be lead plaintiff by May 26, 2026, or risk losing their representation in the class action lawsuit.
- Lawsuit Background: The lawsuit alleges that Vital Farms downplayed the risks associated with delays in the rollout of its new enterprise resource planning (ERP) system and failed to disclose the impact of these delays on its 2025 earnings guidance and earnings per share consensus, resulting in investor losses.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and was ranked No. 1 by ISS Securities Class Action Services in 2017, consistently ranking in the top four since 2013, demonstrating its extensive experience and success in this field.
- Investor Action Advice: Investors can visit the Rosen Law Firm website or call the toll-free number for more information, emphasizing the importance of selecting qualified legal counsel to ensure optimal representation in the lawsuit and avoid inexperienced intermediaries.
See More
- Class Action Notice: Rosen Law Firm reminds investors who purchased Vital Farms securities between May 8, 2025, and February 26, 2026, that they must apply to be lead plaintiff by May 26, 2026, to represent other investors in the class action lawsuit.
- Fee Arrangement: Investors participating in the class action will incur no out-of-pocket expenses, as the law firm operates on a contingency fee basis, which reduces financial barriers and encourages broader participation among affected investors.
- Lawsuit Background: The lawsuit alleges that Vital Farms downplayed the risks associated with delays in rolling out its new ERP system, resulting in the company missing its 2025 earnings guidance, which highlights deficiencies in corporate governance and transparency.
- Law Firm's Strength: Rosen Law Firm is renowned for its successful track record in securities class actions, having recovered over $438 million for investors in 2019 alone, demonstrating its expertise and resource advantages in handling such cases.
See More
- Executive Accountability: Vital Farms' CEO Russel Diez-Canseco and CFO Thilo Wrede are named in a securities class action lawsuit, facing personal liability for signing Sarbanes-Oxley certifications that attested to the accuracy of financial reporting, despite the company missing revenue guidance by over $15 million due to ERP implementation failures.
- Stock Price Impact: Following the company's admission of struggles to regain retail shelf space and missing revenue guidance, Vital Farms' stock plummeted by 10.8% to $22.11 on February 26, 2026, indicating a significant loss of investor confidence in the management team, which could lead to further capital flight.
- Legal Liability Framework: The lawsuit asserts claims under Section 20(a) of the Securities Exchange Act of 1934, alleging that both executives were directly involved in management and bear responsibility for misleading statements, highlighting the critical role of executives in financial transparency and corporate governance.
- Investor Action Guidance: Investors must submit their information by May 26, 2026, to participate in the recovery process; while immediate action is not required, gathering purchase records is essential to ensure eligibility, reflecting an increasing awareness of shareholder rights.
See More











